(Q33627353)

English

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients (English)

1 reference

Europe PubMed Central

28 July 2017

0 references

0 references

author name string

C G Löfdahl

1

1 reference

Europe PubMed Central

28 July 2017

T F Reiss

2

1 reference

Europe PubMed Central

28 July 2017

J A Leff

3

1 reference

Europe PubMed Central

28 July 2017

E Israel

4

1 reference

Europe PubMed Central

28 July 2017

M J Noonan

5

1 reference

Europe PubMed Central

28 July 2017

A F Finn

6

1 reference

Europe PubMed Central

28 July 2017

B C Seidenberg

7

1 reference

Europe PubMed Central

28 July 2017

T Capizzi

8

1 reference

Europe PubMed Central

28 July 2017

S Kundu

9

1 reference

Europe PubMed Central

28 July 2017

P Godard

10

1 reference

Europe PubMed Central

28 July 2017

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

319

1 reference

Europe PubMed Central

28 July 2017

7202

1 reference

Europe PubMed Central

28 July 2017

87-90

1 reference

Europe PubMed Central

28 July 2017

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Dexamethasone increases expression of 5-lipoxygenase and its activating protein in human monocytes and THP-1 cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Use of inhaled corticosteroids and the risk of cataracts.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Effect of oral prednisone on airway inflammatory mediators in atopic asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Lack of benefit of methotrexate in severe, steroid-dependent asthma. A double-blind, placebo-controlled study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

21 June 2018

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=28156

30 October 2018

Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10398629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10398629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of inhaled corticosteroids

1 reference

https://pubmed.ncbi.nlm.nih.gov/10398629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement characteristics of two asthma symptom diary scales for use in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/10398629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10398629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10398629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10398629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10398629

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.319.7202.87

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33627353&oldid=1535131284"